Amylyx Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 10, 2022
04 November 2022 - 7:05AM
Business Wire
Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced it will
report third quarter 2022 financial results on Thursday, November
10, 2022 following the close of the U.S. financial markets. Amylyx’
senior management team will host a conference call and audio
webcast at 4:30 p.m. ET to discuss the financial results and other
company updates.
To access the conference call, please dial (877) 870-4263
(local) or (412) 317-0790 (international) at least 10 minutes prior
to the start time and ask to be joined into the Amylyx
Pharmaceuticals call. A live audio webcast of the call will be
available under “Events and Presentations” in the Investor section
of the Company’s website,
https://investors.amylyx.com/news-events/events. The webcast will
be archived and available for replay for 90 days following the
event.
About Amylyx Pharmaceuticals Amylyx Pharmaceuticals, Inc.
is committed to supporting and creating more moments for the
neurodegenerative community through the discovery and development
of innovative new treatments. Amylyx is headquartered in Cambridge,
Massachusetts and has operations in Canada and EMEA. For more
information, visit amylyx.com and follow us on LinkedIn and
Twitter. For investors, please visit investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221103005256/en/
Media Becky Gohsler Finn Partners (646) 307-6307
amylyxmediateam@amylyx.com Investors Lindsey Allen Amylyx
Pharmaceuticals, Inc. (857) 320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Apr 2023 to Apr 2024